Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Jasmine Hamilton · Senior Advisor, Innovation, Science and Economic Development Canada (ISED)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Brendon Legault · Office of Senator K. Wells, Senate of Canada
Katya Nova · Office of Senator K. Wells, Senate of Canada
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of aging, older adult care, child and youth health, mental health and substance use, palliative care, Indigenous health, public health, and data.
Sheldon Bailey · Senior Policy Advisor, House of Commons
Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of aging, older adult care, child and youth health, mental health and substance use, palliative care, Indigenous health, public health, and data.Read more
Bryce McRae · Manager of Stakeholder Relations, House of Commons
Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of aging, older adult care, child and youth health, mental health and substance use, palliative care, Indigenous health, public health, and data.Read more
Strengthening Canada’s health workforce including through the development of a pan-Canadian health workforce plan.
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.
Sarah MacDonald · Special Assistant (Parliamentary Affairs and Assistant to the Parliamentary Secretary), Innovation, Science and Economic Development Canada (ISED)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Paul Hébert · President, Canadian Institutes of Health Research (CIHR)
Steven Mitchell · Senior Advisor to the Vice-President, Research, Learning Health Systems, Canadian Institutes of Health Research (CIHR)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Amy MacKay · Director of Parliamentary Affairs, Senate of Canada
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Strengthening Canada’s health workforce including through the development of a pan-Canadian health workforce plan.
Grégoire Carrière · Office of Senator Boudreau, Senate of Canada
Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of aging, older adult care, child and youth health, mental health and substance use, palliative care, Indigenous health, public health, and data.Read more
Improving Canada’s physical and digital infrastructure for both health research and healthcare delivery.
Strengthening Canada’s health workforce including through the development of a pan-Canadian health workforce plan.
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.
Tammy Clifford · Acting President, Canadian Institutes of Health Research (CIHR)
Vikesh Srivastava · Director General, Strategic Partnerships and International Relations, Canadian Institutes of Health Research (CIHR)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Nipun Vats · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Desiree Sam · Assistant to the Parliamentary Secretary, Health Canada (HC)
Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of physical and digital infrastructure, health workforce, immigration, aging, older adult care, child and youth health, mental health and substance use, palliative care, cybersecurity, Indigenous health, environment, and data.Read more
Greg Orencsak · Deputy Minister, Health Canada (HC)
Jocelyne Voisin · Assistant Deputy Minister, Health Canada (HC)
Michelle Boudreau · Associate Assistant Deputy Minister, Health Canada (HC)
Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of physical and digital infrastructure, health workforce, immigration, aging, older adult care, child and youth health, mental health and substance use, palliative care, cybersecurity, Indigenous health, environment, and data.Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.